These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6211942)

  • 21. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zimelidine: comparison of different dosage regimes in general practice.
    Watson JM; Tiplady B
    Acta Psychiatr Scand Suppl; 1981; 290():464-70. PubMed ID: 6452806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular, sedative and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers.
    Swift CG; Haythorne JM; Clarke P; Stevenson IH
    Acta Psychiatr Scand Suppl; 1981; 290():425-32. PubMed ID: 6452804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zimelidine - a serotonin uptake blocker in the treatment of phobic anxiety.
    Evans L; Best J; Moore G; Cox J
    Prog Neuropsychopharmacol; 1980; 4(1):75-9. PubMed ID: 6447309
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recently registered drugs].
    Harvengt C
    Acta Clin Belg; 1982; 37(5):325-7. PubMed ID: 6130659
    [No Abstract]   [Full Text] [Related]  

  • 31. Zimelidine in chronic suicidal behaviour.
    O'Connor M; Pettiford J
    Aust N Z J Psychiatry; 1982 Dec; 16(4):296-7. PubMed ID: 6220693
    [No Abstract]   [Full Text] [Related]  

  • 32. Coding and analysis of spontaneously reported symptoms in clinical trials.
    Tiplady B; Elton RA; Loudon JB
    Psychopharmacol Bull; 1983; 19(1):30-2. PubMed ID: 6219417
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
    Brown D; Scott DH; Scott DB; Meyer M; Westerlund D; Lundström J
    Eur J Clin Pharmacol; 1980 Feb; 17(2):111-6. PubMed ID: 6445274
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zimelidine to geriatric patients: a pharmacokinetic and clinical study.
    Dehlin O; Björnsson G; Lundström J
    Acta Psychiatr Scand Suppl; 1981; 290():410-24. PubMed ID: 6452803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of zimelidine, a new antidepressant, on appetite and body weight.
    Simpson RJ; Lawton DJ; Watt MH; Tiplady B
    Br J Clin Pharmacol; 1981 Jan; 11(1):96-8. PubMed ID: 6452151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy].
    Paulsen O; Nilsson LM; Sellin M; Osterlind A; Lundgren M; Fahlesson P
    Lakartidningen; 1983 Jan; 80(1-2):31-2. PubMed ID: 6220186
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of a modified type of zimelidine therapy. A review of current reports].
    Lakartidningen; 1983 May; 80(19):2034-7. PubMed ID: 6224063
    [No Abstract]   [Full Text] [Related]  

  • 40. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
    d'Elia G; Hällström T; Nyström C; Ottosson JO
    Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.